Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
August 04, 2026
August 04, 2026
NEW BRUNSWICK, New Jersey, Aug. 4 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:
* * *
Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
*
NEW BRUNSWICK, N.J. -August 4, 2026 -Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Taubert will retire from her position as E . . .
* * *
Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
*
NEW BRUNSWICK, N.J. -August 4, 2026 -Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Taubert will retire from her position as E . . .
